[Stimulants related mental disorders].
Iyo
Masaomi
M
Department of Psychiatry, Graduate School of Medicine, Chiba University.
Sekine
Yoshimoto
Y
D019969:Amphetamine-Related Disorders / Q000175:diagnosis / Q000523:psychology / Q000628:therapy; D014150:Antipsychotic Agents / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D002560:Cerebrovascular Circulation; D003952:Diagnostic Imaging; D050483:Dopamine Plasma Membrane Transport Proteins; D006801:Humans; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins / Q000502:physiology; D008694:Methamphetamine / Q000009:adverse effects; D009419:Nerve Tissue Proteins; D011613:Psychotherapy; D012657:Self-Help Groups
D014150:Antipsychotic Agents; D000697:Central Nervous System Stimulants; D050483:Dopamine Plasma Membrane Transport Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D008694:Methamphetamine